Office of Biostatistics and Epidemiology
Immediate Office- Steve Anderson, PhD - Risk Assessment Research: Development of Tools that Evaluate and Enhance the Safety of Biologic Products
Division of Biostatistics
- Tie-Hua Ng, PhD - Research in statistical methodology for equivalence testing, interim analysis and migration studies
- Jawahar Tiwari - Evaluation of bioinformatics tools for the analysis of pharmacogenomic and proteomic data from regulatory clinical and non-clinical studies
- Weishi (Vivian) Yuan, PhD - Adaptive Designs for Clinical Trials
- Boris Zaslavsky, PhD - Statistical and bioinformatics tools for the analysis of blood products and pharmacogenomic and proteomic data
Division of Epidemiology
- M. Miles Braun, MD - Director - Applied Public Health Safety Studies of Biologic Products
- Robert Ball, MD - Post-marketing Monitoring of Vaccine Safety
- Dale R. Burwen, MS - Evaluating the safety of influenza and pneumococcal vaccines received by the Medicare population
- Ann W. McMahon, MD - Determinants of Acceptance of Smallpox Vaccination
- Emily Jane Woo - Study of swelling and other reactions to evaluate safety of diphtheria-tetanus-acellular pertussis vaccine